infinityApril 24, 2021 1
Global Cervical Dysplasia Market report has covered and analyzed the potential of Worldwide market Industry and provides statistics and information on market dynamics, market analysis, growth factors, key challenges, major drivers & restraints, opportunities and forecast. This report presents a comprehensive overview, market shares, and growth opportunities of market 2026 by product type, application, key manufacturers and key regions and countries.
The report by Infinity Business Insights titled as Global Cervical Dysplasia Market is a detailed analogy that gives the reader an insight into the intricacies of the various elements like the growth rate, and impact of the socio-economic conditions that affect the market space. An in-depth study of these numerous components is essential as all these aspects need to blend-in seamlessly for businesses to achieve success in this industry.
Hospitals running out of key drug for COVID-19 patients Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
Frank Gunn/The Canadian Press
Ontario physicians have been urged to ration one of only two drugs known to reduce mortality in critically ill COVID-19 patients, a harbinger of what lies ahead for other provinces if the third wave keeps rising and Canada cannot secure more of the medication.
A shortage of the anti-inflammatory drug tocilizumab is just one of the challenges Canadian hospitals face as faster-spreading and more dangerous variants overtake older versions of the coronavirus. British Columbia, Saskatchewan, New Brunswick and Ontario all have more COVID-19 patients in their intensive care units than at any other time during the pandemic.
Focus on Early Detection Boosts Cervical Dysplasia Diagnostics Adoption: Fact.MR
NEW YORK, Feb. 23, 2021 /PRNewswire/ Award winning market research company Fact.MR s global cervical dysplasia diagnostics market projects a positive expansion outlook for 2021, as the drive towards eradicating cervical cancer continues gathering momentum. The report forecasts an optimistic outlook for the long-run, exhibiting a 7% CAGR through 2031.
The World Health Organization proposed its Global Strategy to Accelerate the Elimination of Cervical Cancer initiative in November 2020, outlining three key steps: vaccination, screening and treatment. It estimates that effective implementation of all three initiatives could reduce the burden of new cases by over 40% and 5 million deaths by 2050. Furthermore, an estimated US$ 3.2 will be returned to the economy for every dollar invested through 2050 and beyond.
Share this article
Share this article
ResearchAndMarkets.com s offering.
According to this report the global latent TB market is expected to reach $1,684.86 million in 2027 from $1,131.82 million in 2019. The market is estimated to grow with a CAGR of 5.2% from 2020-2027. The growth of the market is attributed to the increasing prevalence of tuberculosis and government initiatives to promote tuberculosis detection. However, multi drug resistant tuberculosis (MDR-TB) is likely to hamper the growth of the market to a certain extent.
Based on test, the latent TB detection market was segmented into tuberculin skin test (TST) and interferon gamma released assay (IGRA). In 2019, the tuberculin skin test (TST) segment accounted for the highest share in the market and is likely to retain its dominant share. The TST results are obtained in around 48-72 hours. Reading the presence or absence as well as the amount of in duration known as localized swelling does the reading of the test. Alt